Medical Transcription Billing, Corp. (MTBC) Cut to Hold at Zacks Investment Research

Medical Transcription Billing, Corp. (NASDAQ:MTBC) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Friday, August 18th.

According to Zacks, “Medical Transcription Billing, Corp. is a healthcare information technology company. It engages in providing integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. The Company offers revenue cycle, practice management services, patient scheduling, automated appointment reminders, e-prescribing, lab connectivity, and real-time insurance eligibility verification. Transcription Billing, Corp. is headquartered in Somerset, New Jersey. “

Several other equities analysts have also commented on MTBC. Chardan Capital increased their target price on shares of Medical Transcription Billing, Corp. from $1.85 to $2.25 and gave the company a “buy” rating in a report on Monday, May 15th. ValuEngine raised shares of Medical Transcription Billing, Corp. from a “sell” rating to a “hold” rating in a report on Friday, June 2nd.

Shares of Medical Transcription Billing, Corp. (NASDAQ:MTBC) traded down 0.71% during mid-day trading on Friday, hitting $1.39. The company had a trading volume of 81,247 shares. The firm’s 50 day moving average is $1.39 and its 200-day moving average is $1.26. Medical Transcription Billing, Corp. has a 12-month low of $0.29 and a 12-month high of $3.84. The firm’s market cap is $15.92 million.

Medical Transcription Billing, Corp. (NASDAQ:MTBC) last released its earnings results on Thursday, August 3rd. The technology company reported ($0.02) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.17) by $0.15. Medical Transcription Billing, Corp. had a negative net margin of 32.88% and a negative return on equity of 59.52%. The company had revenue of $7.79 million for the quarter. On average, equities analysts expect that Medical Transcription Billing, Corp. will post ($0.69) EPS for the current year.

TRADEMARK VIOLATION NOTICE: “Medical Transcription Billing, Corp. (MTBC) Cut to Hold at Zacks Investment Research” was originally published by BNB Daily and is the property of of BNB Daily. If you are viewing this report on another site, it was stolen and republished in violation of U.S. & international copyright & trademark law. The original version of this report can be read at https://www.baseball-news-blog.com/2017/09/05/zacks-investment-research-downgrades-medical-transcription-billing-corp-mtbc-to-hold-updated.html.

Medical Transcription Billing, Corp. Company Profile

Medical Transcription Billing, Corp. is a healthcare information technology company that provides an integrated suite of Web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. The Company’s offering, PracticePro, allows healthcare practices with the core software and business services on Software-as-a-Service (SaaS) platform.

Get a free copy of the Zacks research report on Medical Transcription Billing, Corp. (MTBC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Medical Transcription Billing Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Transcription Billing Corp. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply